businesspress24.com - PURE Bioscience Hosts Fiscal Q3 Results Conference Call June 11, 2015 to Review Progress of SDC-Base
 

PURE Bioscience Hosts Fiscal Q3 Results Conference Call June 11, 2015 to Review Progress of SDC-Based Food Safety Solutions Strategy

ID: 1363735

(firmenpresse) - SAN DIEGO, CA -- (Marketwired) -- 06/04/15 -- (OTCQB: PURE), creator of the patented silver dihydrogen citrate () antimicrobial, announced today that the Company will host an investor conference call on Thursday, June 11, 2015 at 1:30pm PDT (4:30pm EDT).

In addition to discussion of fiscal third quarter 2015 results, the PURE management team will review:

The progress made to commercialize SDC as a food safety solution, and

Discuss its intent to resubmit its Food Contact Notification (FCN) with the FDA for SDC antimicrobial use in raw poultry processing

The Participant Dial-In Number for the conference call is 1-631-982-4565. Participants should dial in to the call at least five minutes before 1:30pm PDT (4:30pm EDT) on June 11, 2015. The call can also be accessed "live" online at .

A replay of the webcast will be available on the Company''s website (). Also, a replay of the conference call will be available by dialing 1-877-870-5176 (international participants dial 1-858-384-5517) starting June 11, 2015, at 7:30pm Eastern Time through June 25, 2015 at 11:59 pm Eastern Time. Please use PIN Number 906110.

PURE Bioscience, Inc. is focused on developing and commercializing our proprietary antimicrobial products primarily in the food safety arena -- providing solutions to the health and environmental challenges of pathogen and hygienic control. Our technology platform is based on patented stabilized ionic silver, and our initial products contain silver dihydrogen citrate, or SDC. SDC is a broad-spectrum, non-toxic antimicrobial agent, which offers 24-hour residual protection and formulates well with other compounds. As a platform technology, SDC is distinguished from existing products in the marketplace because of its superior efficacy, reduced toxicity and the inability of bacteria to form a resistance to it. PURE is headquartered in El Cajon, California (San Diego metropolitan area). Additional information on PURE is available at





Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause our actual results to differ materially from the forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, the Company''s cash position and liquidity requirements; the Company''s failure to implement or otherwise achieve the benefits of its proposed business initiatives and plans; acceptance of the Company''s current and future products and services in the marketplace, including acceptance of the Company''s PURE Hard Surface disinfectant by SUBWAY® franchisees; and the ability to convert successful evaluations into customer orders; the ability of the Company to develop effective new products and receive required regulatory approvals for such products, including the required data and regulatory approvals required to use its SDC-based technology as a direct food contact processing aid in raw poultry processing; competitive factors; dependence upon third-party vendors, including to manufacture its products; and other risks detailed in the Company''s periodic report filings with the Securities and Exchange Commission, including Forms 10-Q and 10-K. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release.



Peter C. Wulff
CFO & COO
PURE Bioscience, Inc.
619-596-8600 ext.111


Terri MacInnis
VP of IR
Bibicoff + MacInnis, Inc.
818-379-8500


Tom Hemingway
Redwood Investment Group
714-978-4425


Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  PURE Bioscience Prepares to Resubmit Food Contact Notification With FDA for SDC Antimicrobial Use in Raw Poultry Processing
Industrial Nanotech, Inc. Provides Update
Bereitgestellt von Benutzer: Marketwired
Datum: 04.06.2015 - 06:36 Uhr
Sprache: Deutsch
News-ID 1363735
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

SAN DIEGO, CA


Phone:

Kategorie:

Specialty Chemicals


Anmerkungen:


Diese Pressemitteilung wurde bisher 176 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"PURE Bioscience Hosts Fiscal Q3 Results Conference Call June 11, 2015 to Review Progress of SDC-Based Food Safety Solutions Strategy
"
steht unter der journalistisch-redaktionellen Verantwortung von

PURE Bioscience, Inc. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von PURE Bioscience, Inc.



 

Who is online

All members: 10 563
Register today: 0
Register yesterday: 2
Members online: 0
Guests online: 69


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.